Structures by: Bojarska J.
Total: 11
N-fluorenyl-methylen-xycarbonyl-O-tert-butyl-N-methyl-tyrosine; Fmoc-N-Me-Tyr(t-Bu)-OH
C29H31NO5
Acta Crystallographica Section C (2020) 76, 4
a=6.4917(3)Å b=17.5357(7)Å c=22.2418(8)Å
α=90° β=90° γ=90°
Captopril
C9H15NO3S
Acta Crystallographica Section C (2015) 71, 3
a=6.80010(10)Å b=8.8015(2)Å c=17.4805(3)Å
α=90° β=90° γ=90°
Captopril disulfide
C18H28N2O6S2
Acta Crystallographica Section C (2015) 71, 3
a=6.6678(4)Å b=11.0680(6)Å c=14.4219(8)Å
α=90° β=91.925(2)° γ=90°
(1<i>S</i>)-2-((<i>S</i>)-{1-[(2<i>S</i>,3a<i>S</i>,7a<i>S</i>)-2- carboxyoctahydro-1<i>H</i>-indol-1-yl]-1-oxopropan-2-yl}azaniumyl)pentanoate dimethyl sulfoxide hemisolvate
C17H28N2O5,0.5(C2H6OS)
Acta Crystallographica Section C (2012) 68, 9 o341-o343
a=10.3504(7)Å b=16.0908(11)Å c=24.4828(16)Å
α=90° β=90° γ=90°
(1<i>S</i>)-2-((<i>S</i>)-{1-[2<i>S</i>,3a<i>S</i>,7a<i>S</i>)-2- carboxyoctahydro-1<i>H</i>-indol-1-yl]-1-oxopropan-2yl}azaniumyl)pentanoate monohydrate
C17H28N2O5,H2O
Acta Crystallographica Section C (2012) 68, 11 o443-o446
a=8.1645(2)Å b=10.0136(2)Å c=23.2429(5)Å
α=90° β=90° γ=90°
Ethyl (2<i>S</i>)-2-[(3<i>S</i>,5a<i>S</i>,9a<i>S</i>,10a<i>S</i>)-3-methyl-1,4-dioxo-5a,6,7,8,9,9a,10,10a-octahydro-3<i>H</i>-pyrazino[1,2-<i>a</i>]indol-2-yl]pentanoate
C19H30N2O4
Acta Crystallographica Section C (2013) 69, 6 630-633
a=9.2089(10)Å b=17.9875(17)Å c=23.697(2)Å
α=90° β=90° γ=90°
Ethyl (2<i>S</i>)-2-[(3<i>S</i>,5a<i>S</i>,9a<i>S</i>,10a<i>S</i>)-3-methyl-1,4-dioxo-5a,6,7,8,9,9a,10,10a-octahydro-3<i>H</i>-pyrazino[1,2-<i>a</i>]indol-2-yl]pentanoate
C19H30N2O4
Acta Crystallographica Section C (2013) 69, 6 630-633
a=9.2606(8)Å b=9.2606(8)Å c=44.847(4)Å
α=90° β=90° γ=90°
Olanzapine acetic acid monosolvate
C17H20N4S,C2H4O2
Acta Crystallographica Section C (2013) 69, 7 781-786
a=10.14740(10)Å b=12.85620(10)Å c=14.54940(10)Å
α=90° β=92.92° γ=90°
Olanzapine propan-2-ol hemisolvate monohydrate
C17H20N4S,0.5(C3H8O),H2O
Acta Crystallographica Section C (2013) 69, 7 781-786
a=24.5414(4)Å b=12.5088(3)Å c=15.3096(4)Å
α=90° β=125.3140(10)° γ=90°
Olanzapine propan-2-one hemisolvate monohydrate
C17H20N4S,0.5(C3H6O),H2O
Acta Crystallographica Section C (2013) 69, 7 781-786
a=24.5759(14)Å b=12.5608(5)Å c=15.1607(9)Å
α=90° β=125.790(9)° γ=90°
2,9-Di-3-pentylanthra[1,9-<i>def</i>:6,5,10-<i>d</i>'<i>e</i>'<i>f</i>'] diisoquinoline-1,3,8,10-tetrone
C34H30N2O4
Acta Crystallographica Section E (2010) 66, 10 o2570-o2571
a=34.009(4)Å b=7.5035(10)Å c=21.248(3)Å
α=90.00° β=100.562(2)° γ=90.00°